Literature DB >> 10758022

Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications.

L G Miller1, R D Hays.   

Abstract

Adherence to combination antiretroviral therapy has a strong impact on virologic response and emergence of viral resistance. However, monitoring adherence in the clinic is difficult. What a patient says or a clinician believes about a patient's adherence may be misleading. Patients with suboptimal adherence may have reduced or undetectable viral loads. On the other hand, viral load may not decrease in patients with perfect adherence because of pretreatment resistance, poor drug metabolism, or other factors. A multidisciplinary approach involving patients, health care professionals, family, and friends may optimize adherence. This article reviews the literature on adherence to antiretroviral therapy, critiques the various adherence measures used by researchers and clinicians, and discusses the clinical implications of adherence to antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758022

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  17 in total

1.  HIV therapy: managing resistance.

Authors:  D Wodarz; M A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  The second wave will drown us.

Authors:  Michael Gross
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

3.  Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues.

Authors:  Cynthia R Pearson; Jane M Simoni; Peter Hoff; Ann E Kurth; Diane P Martin
Journal:  AIDS Behav       Date:  2007-03

Review 4.  Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Authors:  Jane M Simoni; Ann E Kurth; Cynthia R Pearson; David W Pantalone; Joseph O Merrill; Pamela A Frick
Journal:  AIDS Behav       Date:  2006-05

5.  Problem drinking and medication adherence among persons with HIV infection.

Authors:  R L Cook; S M Sereika; S C Hunt; W C Woodward; J A Erlen; J Conigliaro
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

6.  Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.

Authors:  Eugène Messou; Marie-Laure Chaix; Delphine Gabillard; Albert Minga; Elena Losina; Vincent Yapo; Martial Kouakou; Christine Danel; Caroline Sloan; Christine Rouzioux; Kenneth A Freedberg; Xavier Anglaret
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04       Impact factor: 3.731

7.  Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission.

Authors:  Nicole L Davis; William C Miller; Michael G Hudgens; Charles S Chasela; Dorothy Sichali; Dumbani Kayira; Julie A E Nelson; Jeffrey S A Stringer; Sascha R Ellington; Athena P Kourtis; Denise J Jamieson; Charles van der Horst
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

8.  Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.

Authors:  John C Chalker; Tenaw Andualem; Lillian N Gitau; Joseph Ntaganira; Celestino Obua; Hailu Tadeg; Paul Waako; Dennis Ross-Degnan
Journal:  BMC Health Serv Res       Date:  2010-02-19       Impact factor: 2.655

9.  Assessing relationships between health-related quality of life and adherence to antiretroviral therapy.

Authors:  E Carballo; C Cadarso-Suárez; I Carrera; J Fraga; J de la Fuente; A Ocampo; R Ojea; A Prieto
Journal:  Qual Life Res       Date:  2004-04       Impact factor: 4.147

10.  Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.

Authors:  Aurélia Souares; Patricia Moulin; Sophie Sarrassat; Marie-Paule Carlotti; Richard Lalou; Jean-Yves Le Hesran
Journal:  Malar J       Date:  2009-11-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.